Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corporation    EW

EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/16/2019 09/17/2019 09/18/2019 09/19/2019 09/20/2019 Date
215.09(c) 219.42(c) 217.84(c) 215.11(c) 219.66(c) Last
812 633 885 655 601 518 765 888 1 588 405 Volume
-2.01% +2.01% -0.72% -1.25% +2.12% Change
More quotes
Financials (USD)
Sales 2019 4 238 M
EBIT 2019 1 283 M
Net income 2019 1 067 M
Finance 2019 691 M
Yield 2019 -
Sales 2020 4 702 M
EBIT 2020 1 450 M
Net income 2020 1 213 M
Finance 2020 1 244 M
Yield 2020 -
P/E ratio 2019 44,4x
P/E ratio 2020 38,0x
EV / Sales2019 10,6x
EV / Sales2020 9,45x
Capitalization 45 683 M
More Financials
Company
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - hemodynamic monitoring systems (61.4%); - heart valves and surgery products (20.4%); -... 
More about the company
Surperformance© ratings of Edwards Lifesciences Corpo
Trading Rating : Investor Rating :
More Ratings
Latest news on EDWARDS LIFESCIENCES CORPO
08/28EDWARDS LIFESCIENCES : To Present At The 2019 Wells Fargo Healthcare Conference
PR
08/14NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/26EDWARDS LIFESCIENCES : Management's Discussion and Analysis of Financial Conditi..
AQ
07/23EDWARDS LIFESCIENCES : 2Q Earnings Snapshot
AQ
07/23EDWARDS LIFESCIENCES CORP : Results of Operations and Financial Condition, Finan..
AQ
07/23EDWARDS LIFESCIENCES : Reports Second Quarter Results
PR
07/09EDWARDS LIFESCIENCES : To Host Earnings Conference Call On July 23, 2019
PR
06/24EDWARDS LIFESCIENCES : Comments on Updated TAVR National Coverage Determination
AQ
06/21EDWARDS LIFESCIENCES : Comments On Updated TAVR National Coverage Determination
PR
06/04EDWARDS LIFESCIENCES : To Present At The Goldman Sachs 40th Annual Global Health..
PR
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPO
More recommendations
Sector news : Advanced Medical Equipment & Technology - NEC
09/19ROYAL PHILIPS : Philips to sell remaining 10.7% stake in Signify for 357 million..
RE
09/18Sony Rejects Investor's Call to Spin Off Profitable Unit -- WSJ
DJ
09/17ROYAL PHILIPS : Trade wars, Brexit are 'profit warning', Dutch king says
RE
09/17DANIEL LOEB : Sony rejects Loeb's proposal for chip business spin-off
RE
09/11Dutch government to trim multinational tax deductions - NOS
RE
More sector news : Advanced Medical Equipment & Technology - NEC
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EDWARDS LIFESCIENCES CORPO
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 220,16  $
Last Close Price 219,66  $
Spread / Highest target 16,1%
Spread / Average Target 0,23%
Spread / Lowest Target -22,6%
EPS Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John P. McGrath Vice President-Quality, Regulatory & Clinical
William J. Link Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES CORPORATION43.41%45 683
THERMO FISHER SCIENTIFIC32.41%118 673
DANAHER CORPORATION42.04%105 073
INTUITIVE SURGICAL10.91%61 218
BOSTON SCIENTIFIC CORPORATION22.50%60 302
ILLUMINA, INC.3.21%45 507